FDA Approved: BAQSIMI — Supplemental Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BAQSIMI (glucagon) from Amphastar Pharmaceuticals, Inc., the nasal glucagon product for emergency treatment of s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• BAQSIMI (Glucagon)

Snippet

SUPPL AP for BAQSIMI (GLUCAGON)